Evidence map›Paper›PMID 16399990›Full record

ArticleAmerican journal of respiratory and critical care medicine2006

Immunoglobulin G levels before and after lung transplantation.

Natalie H Yip, David J Lederer, Steven M Kawut, Jessie S Wilt, Frank D'Ovidio, Yuanjia Wang, Edward Dwyer, Joshua R Sonett, Selim M Arcasoy

Registry-linked trialAbstract readComparative Study
In one paragraph

Article in American journal of respiratory and critical care medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02690038 (Feasibility and Safety of Immunoglobulin), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02690038 phase2completednot on this mapstarted 2016, after this paper: background citation

Feasibility and Safety of Immunoglobulin (Ig) Prophylactic Treatment in COPD Patients With Frequent Exacerbations: A Pilot Study

TypeinterventionalSponsorOttawa Hospital Research InstituteRan2016 to 2019Enrolled48ConditionsChronic Obstructive Pulmonary DiseaseArmsIntravenous immunoglobulin (IVIG), Normal Saline
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 61 citations in OpenAlex.

  1. Trial
  2. Acquired hypogammaglobulinemia in HIV-positive subjects after liver transplantation.Transplant infectious disease : an official journal of the Transplantation Society · 2013
    Trial
  3. Low immunoglobulin levels affect the course of COPD in hospitalized patients.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2023
    Article
  4. Article
  5. Article
  6. Bacterial infections in lung transplantation.Journal of thoracic disease · 2021
    Review
  7. Immunoglobulin deficiency as an indicator of disease severity in patients with COVID-19.American journal of physiology. Lung cellular and molecular physiology · 2021
    Article
  8. Hypogammaglobulinemia and Risk of Exacerbation and Mortality in Patients with COPD.International journal of chronic obstructive pulmonary disease · 2020
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Natalie H YipDepartment of Medicine ad Surgery, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
David J Lederer
Steven M Kawut
Jessie S Wilt
Frank D'Ovidio
Yuanjia Wang
Edward Dwyer
Joshua R Sonett
Selim M Arcasoy
Columbia University · US

Funding

Neurohormonal Activation in Pulmonary HypertensionK23HL067771 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KAWUT, STEVEN M · 2001 to 2005
$641k
NHLBI NIH HHS HL67771
6 · The paper itself

Abstract

rationaleThe determinants of immunoglobulin G (IgG) level and the risk of hypogammaglobulinemia (HGG) in patients with severe lung disease before and after lung transplantation are unknown.

objectivesWe aimed to identify predictors of low IgG levels before and after lung transplantation.

methodsWe performed a retrospective cohort study of 40 consecutive lung transplant recipients at our center. Total IgG levels were measured before and serially after transplantation. Mild HGG was defined as IgG levels from 400-699 mg/dl; severe HGG was defined as IgG levels<400 mg/dl. MEASUREMENTS AND MAIN

resultsBefore transplantation, six (15%) patients had mild HGG, and none had severe HGG. Patients with chronic obstructive pulmonary disease had lower IgG levels compared with patients with other diseases (independent of corticosteroid use and age; p=0.001) and an increased risk of mild HGG (p=0.005). The cumulative incidences of mild and severe HGG significantly increased after transplantation (58 and 15%, respectively, both p<0.04 compared with pretransplant prevalences). Lower pretransplant IgG level and treatment with mycophenolate mofetil were associated with lower IgG levels after transplantation (both p<0.05). Only lower pretransplant IgG levels were significantly associated with an increased risk of severe HGG after transplantation (p=0.02).

conclusionsMild HGG is common in patients with severe chronic obstructive pulmonary disease, and the incidences of mild and severe HGG increase significantly early after lung transplantation. Baseline IgG levels and treatment with mycophenolate mofetil affect post-transplant IgG levels.

Indexed as

Lung TransplantationBiomarkersDisease ProgressionFemaleFollow-Up StudiesHumansHypergammaglobulinemiaImmunoglobulin GMaleMiddle AgedPulmonary Disease, Chronic ObstructiveRetrospective StudiesRisk FactorsSeverity of Illness IndexTime FactorsBiomarkersImmunoglobulin G

Identifiers

PMID16399990
PMCPMC2662910
OpenAlexW2164581678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.